fda indications for semaglutide TrimRX Novo's Wegovy adds another indication

Generic vs Generic Also, we may use the term generic when referring to our compounding pharmacy version of semaglutide

Tirzepatide dosing protocol Tirzepatide follows a well-established escalation schedule refined through multiple clinical trials and years of real-world use: Weeks 1-4: 2.5 mg once weekly (starting dose) Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly (optional intermediate step) Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly (optional intermediate step) Week 21+: 15 mg once weekly (maximum dose) The starting dose of 2.5 mg is intentionally subtherapeutic

In contrast to pioglitazone, saroglitazar does not seem to correlate with weight gain and peripheral edema [66]

The answer is personal